Grid Therapeutics
Pre-clinicalDevelops antibody-based cancer immunotherapies targeting novel tumor antigens.
Founded
2015
Focus
AntibodiesBiologics
About
Develops antibody-based cancer immunotherapies targeting novel tumor antigens.
Funding History
2Total raised: $25M
Series A$20MMorningside VenturesJun 15, 2021
Seed$5MUndisclosedJun 15, 2019
Company Info
TypePrivate
Founded2015
LocationDurham, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile